Follow Us:
Flupirtine Exporter From India

Flupirtine

Flupirtine is a centrally acting analgesic formerly used to treat acute and chronic pain, including musculoskeletal pain. It belongs to the class of non-opioid analgesics and selective neuronal potassium channel openers. Flupirtine works by activating neuronal potassium channels, stabilizing nerve cell membranes and reducing excessive neuronal excitability and pain transmission. It was administered orally as capsules or tablets. Common side effects include dizziness, fatigue, nausea, and drowsiness. Serious adverse effects include severe liver injury, which led to its withdrawal or restriction in several countries, including the European Union.

  • Dosage Form:
  • Dosage Strength:
  • Manufacturer:
  • CAS No.:
  • Status:

Applications of Flupirtine

Flupirtine was historically used as a respiratory medicine for the symptomatic management of certain respiratory conditions. Its former uses included:

is okay

Contraindication of Flupirtine

Availability of Flupirtine

Delivery of Flupirtine

Frequently Asked Questions

The most frequently asked questions focus on import, export, documentations, and regulation for Flupirtine.

The is a pharmaceutical active pharmaceutical ingredient (API) used in manufacturing of Flupirtine.

: Provides active pharmaceutical ingredients (APIs), customized production, and OEM/ODM services with research and technical cooperation across Europe, the USA, and India via Primeera Healthcare.

  • Therapeutic Goods Administration (TGA):
  • US Food and Drug Administration (USFDA):
  • European Medicines Agency (EMA):
  • African Medicines Agency (AMA):
  • National Medical Products Administration (NMPA):
  • Central Drugs Standard Control Organization (CDSCO):

Primeera Healthcare Private Limited can provide import coordination and pharmaceutical documentation assistance for Flupirtine, subject to confirmation of its current regulatory status and eligibility for import into India.

Documentation Required for Flupirtine Import

The import of medicines into India is regulated by the Central Drugs Standard Control Organisation (CDSCO) under the Drugs and Cosmetics Act, 1940, and the Drugs and Cosmetics Rules, 1945. The regulatory requirements depend on whether the product is an active pharmaceutical ingredient (API), a finished formulation, or an unapproved medicine intended for an individual patient's treatment.

Import Regulations and dcoumentation for Flupirtine

  • Import Documentation Assistance:
    Support with organising commercial invoices, packing lists, manufacturer details, product specifications, certificates of analysis, and other relevant documents required for regulatory review and customs processing.

  • Regulatory Coordination:
    Assistance with identifying applicable CDSCO requirements, import authorisations, and documentation procedures, subject to the product's regulatory status and the proposed import route.
  • Shipping and Customs Coordination:
    Coordination with relevant logistics providers and customs professionals to organise shipment documentation and facilitate clearance where legally permitted.
  • Compliance Verification:
    Preliminary review of available product and shipment documentation to identify potential regulatory gaps before procurement or dispatch. Import arrangements will proceed only after the applicable permissions and restrictions have been verified.

Customs Clearance and Compliance Handling of Flupirtine Import

Primeera Healthcare Private Limited can provide import coordination and pharmaceutical documentation assistance for Flupirtine, subject to confirmation of its current regulatory status and eligibility for import into India.

Export Regulations and dcoumentation for Flupirtine

The export of Flupirtine from India is subject to applicable requirements under the Drugs and Cosmetics Act, 1940, the Drugs and Cosmetics Rules, 1945, and relevant export, customs, and destination-country regulations. Documentation requirements depend on whether the product is an active pharmaceutical ingredient (API), a finished pharmaceutical formulation, or a medicine intended for a specific market. Export eligibility and destination-country requirements must be verified before shipment.

Documentation Required for Flupirtine Emport

  • Export Documentation Assistance:
    Assistance with organising commercial invoices, packing lists, manufacturer details, Flupirtine specifications, certificates of analysis, and other supporting documents required for Flupirtine export and customs processing.
  • Regulatory Coordination:
    Support in identifying applicable country specific Flupirtine export requirements, relevant manufacturing and export authorisations, and destination-country registration or import approval requirements, subject to the Flupirtine regulatory status.
  • Shipping and Customs Coordination:
    Coordination with logistics providers, freight forwarders, and customs professionals to organise shipping documentation, export declarations, and customs clearance procedures where legally permitted.
  • Compliance Verification:
    Preliminary review of available Flupirtine documentation, labelling, Flupirtine manufacturing information, and destination-market requirements to identify potential regulatory gaps before dispatch. Export arrangements will proceed only after the applicable restrictions and authorisations have been verified.

Customs Clearance and Compliance Handling of Flupirtine Export

Primeera Healthcare Private Limited can provide pharmaceutical export documentation assistance, regulatory coordination, and shipping support for Flupirtine, subject to confirmation of its export eligibility under applicable Indian regulations and the import requirements of the destination country.

Product Export Support

If you have any questions or need any help, contact our Support Team. We will get in touch with you within 24 hours from Monday to Friday between 9:00 and 10:00 CET.

Email Us

info@primeerahealthcare.com

Call Us

+(123) 456 789 00

Follow Us

Primeera Healthcare

Disclaimer

All Trademarks and Brands that appear on the website belong to their respective owners. Primeera Healthcare does not lay any claim on them; we only provide information.